Glenmark Pharmaceuticals Limited header image

Glenmark Pharmaceuticals Limited

532296

Equity

ISIN INE935A01035 / Valor 3195888

Bombay Stock Exchange Ltd. (Mumbai) (2026-11-11)
INR 2,675.00-0.18%

Glenmark Pharmaceuticals Limited
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Glenmark Pharmaceuticals Limited is an India‑headquartered multinational drug company that researches, develops, manufactures and markets prescription and over‑the‑counter medicines across multiple geographies. Its commercial business combines branded generics in India and other emerging markets with generic and specialty products sold in developed markets such as the United States and Europe; key therapeutic areas include respiratory, dermatology and oncology, and the company has pursued biosimilars and novel small molecules through its R&D pipeline. Glenmark operates manufacturing and research facilities domestically and abroad and distributes products via subsidiaries and partner networks, pairing ongoing regulatory filings and clinical development with the sale of marketed pharmaceuticals.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

47.1%1Y
244%3Y
419%5Y

Performance

28.0%1Y
30.6%3Y
31.4%5Y

Volatility

Market cap

8037 M

Market cap (USD)

Daily traded volume (Shares)

39,257

Daily traded volume (Shares)

1 day high/low

/

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

MEDICLIN AG
MEDICLIN AG MEDICLIN AG Valor: 1158721
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 5.40
Fagron SA
Fagron SA Fagron SA Valor: 3425437
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.62%EUR 24.20
Demant A/S
Demant A/S Demant A/S Valor: 32651962
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-8.32%DKK 339.40
McKesson Corp
McKesson Corp McKesson Corp Valor: 991041
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.25%USD 1,077.05
Takeda Yakuhin Kogyo KK
Takeda Yakuhin Kogyo KK Takeda Yakuhin Kogyo KK Valor: 11292411
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.34%USD 21.12
Lineage Inc
Lineage Inc Lineage Inc Valor: 136372357
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.49%USD 35.40
Limes Schlosskliniken AG
Limes Schlosskliniken AG Limes Schlosskliniken AG Valor: 38625581
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.61%EUR 590.00
MPH Health Care AG
MPH Health Care AG MPH Health Care AG Valor: 57233620
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.53%EUR 31.00
Legend Biotech Corporation
Legend Biotech Corporation Legend Biotech Corporation Valor: 54834759
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.26%USD 19.54
Alk-Abello A/S
Alk-Abello A/S Alk-Abello A/S Valor: 117689788
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.40%DKK 248.80